Saving Limbs. Saving Lives.
Protecting patients from serious, life-altering complications stemming from plaque and thrombus induced micro-circulatory injury & contrast-induced renal injury during Peripheral Artery Disease interventions.
How Protexa is different
Challenging the Status Quo
PAD interventions liberate micro & macro-emboli. For too long this has been deemed "the cost of doing business" when treating this patient population.
>800K US Cases/Yr
Peripheral Arterial Disease (PAD) is on the rise. The increasing severity of the disease has increased the complexity of interventions.
Occurence
Micro-circulatory injury resulting from downstream migration of thrombus & plaque post-intervention. All interventions liberate debris.
Difficult to Detect
Purpose Built Solution
The Protexus Catheter
Protexa is primed to transform the standard of care in PAD treatment through its innovation in the Protexus catheter.
The Protexus - Numerous clinical advantages
Simplifying Procedures
One Device, countless benefits. Only platform in PAD to capture micro & macro debris. Protect from micro and macro-circulatory injury. Reduce contrast exposure. Enabling active primary and secondary thrombectomy. Support for lesion crossing. Streamline procedural workflow.
Team
Pioneering Novel Advancements
Protexa Endovascular is devoted to improving life for patients suffering from vascular disease.
Designed by Clinicians for Clinicians
Decades of Expertise in PAD with Diverse Team of KOL's Serving on Medical Advisory Board
Founding Executive Team has Deep Expertise Designing, Developing & Commercializing Meaningful Medical Device Innovations
Contact Us
Protexa Endovascular
Interested in learning more?
© Untitled. All rights reserved. Protexa and Protexus are trademarks of Protexa Endovascular, Inc.